Moïshe Liberman

机构：Lung Institute, Centre Hospitalier de l’Université de Montréal, Université Laval, Université de Montréal · ORCID：0000-0002-9964-1232

发表论文 273 篇 · 总被引 10851 次 · h-index 45

代表论文

• Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer (2025 · New England Journal of Medicine · 被引 311)
• Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer (2025 · New England Journal of Medicine · 被引 228)
• Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial (2025 · Nature Medicine · 被引 41)
• Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable gastric/gastroesophageal junction cancer (GC/GEJC). (2025 · Journal of Clinical Oncology · 被引 15)
• American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer (2025 · Journal of Bronchology & Interventional Pulmonology · 被引 13)
• Intercostal cryoanalgesia for acute pain after video-assisted thoracic surgery lung resection: A randomized controlled preliminary trial (2025 · Journal of Thoracic and Cardiovascular Surgery · 被引 11)